Theodore Brown, MD
Physical Medicine & Rehabilitation · Kirkland, WANPI 1568416873
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $42,194 of the $61,764 with a category attached, or 68.3%. It is spread thinly across 44 manufacturers, the largest accounting for just 20.8%. Reporting peaked in 2019 at $20,989 and has fallen 92.0% since, to $1,689 in 2025. Among physical medicine & rehabilitation clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 322 payments — averaging $191.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$13K
- Bristol Myers Squibb$12K
- Sanofi$9K
- Novartis$8K
- Merck Kgaa$7K
- Greenwich Biosciences, Inc.$7K
- plus $6K from 38 others
Across 318 payments — averaging $13,950 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$2.2M
- Genentech, Inc.$1M
- TG Therapeutics, Inc.$387K
- AbbVie$236K
- Adamas Pharmaceuticals, Inc.$177K
- Merck$148K
- plus $245K from 5 others
What the payments were for
- Consulting fees$8,50914%
- Speaking & faculty fees$42,19468%
- Travel & lodging$3,5716%
- Food & beverage$7,03711%
- Education$4541%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$61,764 in reported general payments places this provider in the 95th percentile of 260 physical medicine & rehabilitation providers in Washington.
See all physical medicine & rehabilitation providers in Washington →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CopaxoneGlatiramer Acetate | 38 | $214,952 |
| Glatiramer Acetate | 45 | $167,846 |
| GlatopaGlatiramer Acetate | 48 | $163,558 |
| Teriflunomide | 51 | $103,104 |
| Avonex Pen (4 Pack)Interferon Beta-1a | 12 | $98,674 |
| Avonex (4 Pack)Interferon Beta-1a | 11 | $89,866 |
| BafiertamMonomethyl Fumarate | 13 | $83,627 |
| FingolimodFingolimod Hcl | 47 | $78,215 |
| Dalfampridine ErDalfampridine | 86 | $30,173 |
| Dimethyl Fumarate | 96 | $27,896 |
| MyrbetriqMirabegron | 33 | $23,177 |
| Baclofen | 229 | $6,600 |
| GemtesaVibegron | 13 | $6,022 |
| Modafinil | 93 | $4,782 |
| Gabapentin | 198 | $4,192 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Copaxone | $224 | $214,95238 claims |
| BiogenAvonex (4 Pack) | $116 | $89,86611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 260 physical medicine & rehabilitation providers in Washington.
Other physical medicine & rehabilitation in Kirkland
- Yung LeeKirkland$5K
- Matthew LacourseKirkland$3K
- Kyle OhKirkland$3K
- Ryan ZehnderKirkland$2K
- Nassim RadSeattle$231K
- Nelson HagerTacoma$186K
- Martin ChildersSeattle$170K
- Angeli MayadevSeattle$51K
- Ronan CahillBellevue$22K
- Karen StanekSpokane$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.